This inventor holds 4 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2016-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- South San Francisco, CA (US) (2016)
- Foster City, CA (US) (2020 - 2021)
Company Filing History:
Years Active: 2016-2021
Title: Ganesh A Kolumam: Innovator in Cardiovascular Treatments
Introduction
Ganesh A Kolumam is a prominent inventor based in Foster City, CA (US). He has made significant contributions to the field of medicine, particularly in the development of innovative treatments for cardiovascular conditions. With a total of 4 patents to his name, Kolumam's work is paving the way for new therapeutic approaches.
Latest Patents
Kolumam's latest patents focus on methods for preventing or treating cardiovascular conditions using IL-22 Fc fusion proteins. The inventions relate to IL-22 polypeptides, IL-22 Fc fusion proteins, and IL-22 agonists. These compositions are designed for the treatment of various diseases. Additionally, the patents include pharmaceutical compositions of IL-22 Fc fusion proteins, emphasizing the importance of IL-22 receptor-associated reagents and their methods of use.
Career Highlights
Ganesh A Kolumam is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to focus on groundbreaking research that addresses critical health issues.
Collaborations
Kolumam has collaborated with notable colleagues, including Justin M Scheer and Wenjun Ouyang. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Ganesh A Kolumam is a distinguished inventor whose work in cardiovascular treatments is making a significant impact in the medical field. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile